Cruz LLE, Valenzuela CCR, León RCP, Cieza ZJA

Language: Spanish
References: 18
Page: 48-54
PDF size: 280.62 Kb.

ABSTRACT

Hemoperfusion is a technique for extracorporeal clearance of medium and large molecular weight molecules, lipophilic and highly bound to plasma proteins based on the physical principle of adsorption. It can be used in isolation or in combination with other techniques such as conventional hemodialysis, hybrid hemodialysis or continuous renal replacement therapy. Three patients (two with severe pancreatitis and one with leptospirosis-associated sepsis) in which hemoperfusion combined with conventional hemodialysis in the Intensive Care Unit are reported. All three cases developed in addition to acute kidney injury. Significant clearance of uremic toxins and proinflammatory cytokines is evident, in addition to other molecules such as digestive enzymes and creatine phosphokinase. The future of this innovative adsorptive technique in the treatment of systemic inflammatory conditions requires even more evidence to demonstrate its benefit in the mortality of critically ill patients.

REFERENCES

1. Gurland HJ, Davison AM, Bonomini V, FalkenhagenD, Hansens S, Kishimoto T, et al. Definitions andterminology in biocompatibility. Nephrol DialTransplant. 1994;9(Suppl. 2):4-10.

2. Muirhead EE, Reid AF. A resin artificial kidney. J LabClin Med. 1948;33(7):841-4.

3. Daurgidas JT, Blaker PG, Ing TS. Manual de diálisis. 5aed. Barcelona: Wolters Kluwer, 2015.

4. Ankawi G, Fan W, Pomarè Montin D, Lorenzin A,Neri M, Caprara C, et al. A new series of sorbentdevices for multiple clinical purposes: current evidenceand future directions. Blood Purif. 2019;47(1-3):94-100. doi: 10.1159/000493523.

5. Li Z, Wang G, Zhen G, Zhang Y, Liu J, Liu S. Effectsof hemodialysis combined with hemoperfusionon severe acute pancreatitis. Turk J Gastroenterol.2018;29(2):198-202. doi: 10.5152/tjg.2018.17415.

6. Pomarè Montin D, Ankawi G, Lorenzin A, Neri M,Caprara C, Ronco C. Biocompatibility and CytotoxicEvaluation of New Sorbent Cartridges for BloodHemoperfusion. Blood Purif. 2018;46(3):187-95. doi:10.1159/000489921.

7. Honoré PM, De Bels D, Barreto Gutierrez L, SpapenHD. Hemoadsorption therapy in the critically ill: solidbase but clinical haze. Ann Intensive Care. 2019;9(1):22.doi: 10.1186/s13613-019-0491-1.

8. Liu LY, Zhu YJ, Li XL, Liang YF, Liang ZP, Xia YH.Blood hemoperfusion with resin adsorption combinedcontinuous veno-venous hemofiltration for patientswith multiple organ dysfunction syndrome. World JEmerg Med. 2012;3(1):44-8. doi: 10.5847/wjem.j.issn.1920-8642.2012.01.008.

9. Hato T, Dagher PC. How the innate immune systemsenses trouble and causes trouble. Clin J Am Soc Nephrol.2015;10(8):1459-69. doi: 10.2215/CJN.04680514.

10. Weisheit CK, Engel DR, Kurts C. Dendritic cellsand macrophages: sentinels in the kidney. Clin JAm Soc Nephrol. 2015;10(10):1841-51. doi: 10.2215/CJN.07100714.

11. Tsujimoto H, Ono S, Hiraki S, Majima T,Kawarabayashi N, Sugasawa H, et al. Hemoperfusionwith polymyxin B-immobilized fibers reduced thenumber of CD16+ CD14+ monocytes in patients withseptic shock. J Endotoxin Res. 2004;10(4):229-37. doi:10.1179/096805104225005814.

12. Wang YT, Fu JJ, Li XL, Li YR, Li CF, Zhou CY. Effectsof hemodialysis and hemoperfusion on inflammatoryfactors and nuclear transcription factors in peripheralblood cell of multiple organ dysfunction syndrome.Eur Rev Med Pharmacol Sci. 2016;20(4):745-50.

13. Sato N, Kojima K, Horio Y, Goto E, MasunagaA, Ichiyasu H, et al. Successful treatment of severeamiodarone pulmonary toxicity with polymyxinB-immobilized fiber column direct hemoperfusion.Chest. 2013;143(4):1146-50. doi: 10.1378/chest.12-0994.

14. Li WH, Yin YM, Chen H, Wang XD, Yun H, LiH, et al. Curative effect of neutral macroporousresin hemoperfusion on treating hemodialysispatients with refractory uremic pruritus. Medicine(Baltimore). 2017;96(12):e6160. doi: 10.1097/MD.0000000000006160.

15. Schädler D, Pausch C, Heise D, Meier-HellmannA, Brederlau J, Weiler N, et al. The effect of a novelextracorporeal cytokine hemoadsorption device onIL-6 elimination in septic patients: A randomizedcontrolled trial. PLoS One. 2017;12(10):e0187015. doi:10.1371/journal.pone.0187015.

16. Huang Z, Wang SR, Su W, Liu JY. Removal of humoralmediators and the effect on the survival of septicpatients by hemoperfusion with neutral microporousresin column. Ther Apher Dial. 2010;14(6):596-602.doi: 10.1111/j.1744-9987.2010.00825.x.

17. Hong B, Ling Z, Songmin H, Tao Z, RuichaoY. Continuous venovenous hemofiltrationand hemoperfusion in successful treatmentof a patient with crush syndrome and acutepancreatitis. Ren Fail. 2012;34(3):383-6. doi:10.3109/0886022X.2011.647370.

18. Hu XB, Gao HB, Liao ME, He MR. The use ofHA330-II microporous resin plasma adsorption in thetreatment of chronic severe hepatitis. Zhongguo WeiZhong Bing Ji Jiu Yi Xue. 2007;19(12):760-1.